Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.

Cummings DM, André VM, Uzgil BO, Gee SM, Fisher YE, Cepeda C, Levine MS.

J Neurosci. 2009 Aug 19;29(33):10371-86. doi: 10.1523/JNEUROSCI.1592-09.2009.

2.

Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease.

Indersmitten T, Tran CH, Cepeda C, Levine MS.

J Neurophysiol. 2015 Apr 1;113(7):2953-66. doi: 10.1152/jn.01056.2014. Epub 2015 Feb 11.

3.

Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease.

Cummings DM, Cepeda C, Levine MS.

ASN Neuro. 2010 Jun 18;2(3):e00036. doi: 10.1042/AN20100007.

4.

Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.

Farrar AM, Callahan JW, Abercrombie ED.

Exp Neurol. 2011 Dec;232(2):119-25. doi: 10.1016/j.expneurol.2011.08.010. Epub 2011 Aug 16.

PMID:
21864528
5.

Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.

Cepeda C, Hurst RS, Calvert CR, Hernández-Echeagaray E, Nguyen OK, Jocoy E, Christian LJ, Ariano MA, Levine MS.

J Neurosci. 2003 Feb 1;23(3):961-9.

6.

Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models.

Cepeda C, Galvan L, Holley SM, Rao SP, André VM, Botelho EP, Chen JY, Watson JB, Deisseroth K, Levine MS.

J Neurosci. 2013 Apr 24;33(17):7393-406. doi: 10.1523/JNEUROSCI.2137-12.2013.

7.

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.

Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, Levine MS.

J Neurophysiol. 2001 Dec;86(6):2667-77.

8.

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

André VM, Cepeda C, Venegas A, Gomez Y, Levine MS.

J Neurophysiol. 2006 Apr;95(4):2108-19. Epub 2005 Dec 28.

9.

Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.

Cepeda C, Starling AJ, Wu N, Nguyen OK, Uzgil B, Soda T, André VM, Ariano MA, Levine MS.

J Neurosci Res. 2004 Dec 15;78(6):855-67.

PMID:
15505789
10.

Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.

Starling AJ, André VM, Cepeda C, de Lima M, Chandler SH, Levine MS.

J Neurosci Res. 2005 Nov 1;82(3):377-86.

PMID:
16211559
11.
12.

A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.

Cummings DM, Alaghband Y, Hickey MA, Joshi PR, Hong SC, Zhu C, Ando TK, André VM, Cepeda C, Watson JB, Levine MS.

J Neurophysiol. 2012 Jan;107(2):677-91. doi: 10.1152/jn.00762.2011. Epub 2011 Nov 9.

13.

Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice.

Centonze D, Rossi S, Prosperetti C, Tscherter A, Bernardi G, Maccarrone M, Calabresi P.

Biol Psychiatry. 2005 Jun 15;57(12):1583-9.

PMID:
15953496
14.

Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease.

Miller BR, Walker AG, Shah AS, Barton SJ, Rebec GV.

J Neurophysiol. 2008 Oct;100(4):2205-16. doi: 10.1152/jn.90606.2008. Epub 2008 Jul 30.

15.

Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington's disease.

Murmu RP, Li W, Holtmaat A, Li JY.

J Neurosci. 2013 Aug 7;33(32):12997-3009. doi: 10.1523/JNEUROSCI.5284-12.2013.

16.
17.

Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.

Murphy KP, Carter RJ, Lione LA, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ.

J Neurosci. 2000 Jul 1;20(13):5115-23.

18.

Reduced tonic inhibition in striatal output neurons from Huntington mice due to loss of astrocytic GABA release through GAT-3.

Wójtowicz AM, Dvorzhak A, Semtner M, Grantyn R.

Front Neural Circuits. 2013 Nov 26;7:188. doi: 10.3389/fncir.2013.00188. eCollection 2013.

19.

Altered information processing in the prefrontal cortex of Huntington's disease mouse models.

Walker AG, Miller BR, Fritsch JN, Barton SJ, Rebec GV.

J Neurosci. 2008 Sep 3;28(36):8973-82. doi: 10.1523/JNEUROSCI.2804-08.2008.

20.

Age-dependent biphasic changes in ischemic sensitivity in the striatum of Huntington's disease R6/2 transgenic mice.

Klapstein GJ, Levine MS.

J Neurophysiol. 2005 Feb;93(2):758-65. Epub 2004 Sep 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk